March 14, 2012 ·
Leave a comment
Industry Insights from Brian Castle
As in nearly all other aspects of life, social media is fast becoming a dominant force in the world of healthcare. Leading centers of excellence—hospitals, clinics, research foundations, and universities—are utilizing social media to educate patients about medical resources and treatments on a daily basis. Biopharmaceutical companies are using social media to promote new medications and further educate patients about other wellness resources at their disposal to help with debilitating diseases and conditions.
Physicians and other healthcare professionals, like practically every other profession, are embracing social media at unprecedented levels, engaging with each other on everything from new medical devices to tough medical cases. Due to this rise in HCP use of social media, some have begun to question the very essence of what makes a key opinion leader in the medical profession.
Some of these questioners have gone a step farther, at their ultimate peril, in misinterpreting physician involvement in spaces like Twitter, Facebook, LinkedIn and physician-only social media networks like Sermo. They incorrectly perceive that social media participation is the new thought leadership. Last year, I sat in the audience for a presentation by a leader in the pharmaceutical industry. This person posited a talking point she’d heard from an executive at a physician-only social media network: “If you’re not in their social network, you’re not ... read more »
January 12, 2012 ·
Leave a comment
By Brian Castle and Kristen Smithwick
When most people think about thought leaders in medicine, specialists in oncology, neurology, rheumatology and other therapeutic areas immediately come to mind. However, with the proliferation of illnesses and conditions ranging from diabetes and obesity to asthma, gastrointestinal diseases and psychiatric disorders, key opinion leaders in primary care and allied health professions are more important than ever.
In addition to the growing incidence of several “lifestyle” conditions, the structure of U.S. healthcare dictates that people suffering in these areas see their primary care physicians (PCPs), nurses, nurse practitioners, physician assistants, and pharmacists with much greater frequency than their specialists. As a result, more PCPs and allied health professionals are joining their specialist colleagues in all of the critical areas that define thought leadership, including publishing, basic and clinical research, clinical practice, speaking, and advocacy involvement.
Thought Leader Select has conducted multiple assessments of thought leader populations in a variety of therapeutic areas, with particular attention to the impact of PCPs, also known as general practitioners, in areas of treatment as diverse as diabetes, allergies, infectious disease, and gastrointestinal conditions. Primary care physicians, along with their nurse practitioner (NP), physician assistant (PA), and registered nurse colleagues, consistently distinguish themselves in many of the traditional areas of thought leadership once assumed to be the domain of specialists and sub-specialists.
Leaders ... read more »
September 14, 2010 ·
Leave a comment
Health care systems across the globe rely on the advice and counsel of health care professionals (HCPs) when making decisions on new therapies to approve appropriate levels of reimbursement for various pharmaceutical products. These regulatory and reimbursement advisers have various backgrounds, including health outcomes and economics, clinical pharmacy and medicine.
Within each medical discipline, certain physicians regularly advise government regulatory agencies and public and private insurers on which therapies meet unmet medical demands and have the lowest risk for adverse reactions as well as provide input into reimbursement considerations. Each key opinion leader (KOL) assessment conducted by Thought Leader Select includes an examination of KOL engagement in regulatory and reimbursement activities.
In an ongoing assessment of nearly more than 150 HIV key opinion leaders across the globe, Thought Leader Select has analyzed their participation in regulatory and reimbursement activities. Using keywords to link these KOLs with such activities, Thought Leader Select found that 33% of physicians regularly provide input into regulatory and reimbursement decisions. The 53 KOLs with regulatory and reimbursement involvement are split nearly in half according to their participation in general or HIV-related activities (see Chart 1). However, the majority of Thought Leaders studied are involved in public reimbursement efforts (see Chart 2). Common regulatory and reimbursement groups among studied ... read more »